Devices › Device types
FDA product code NKE · class 3 · Unknown
Pulse generator, pacemaker, implantable, with cardiac resynchronization (crt-p): medical device reports filed with FDA
14,671 reports carry this product code, 2004–2026; 30 brands with a page.
- 14,671
- reports with this product code
- 0.1% of all MAUDE reports
- 2,994
- reports, 12 months to August 2026
- 1,559 in the 12 months before
- 43.9%
- classified as malfunction
- 62.3% across all reports
- 1.9%
- classified as death, as reported
- 0.9% across all reports
Product code NKE is FDA's classification for "Pulse generator, pacemaker, implantable, with cardiac resynchronization (crt-p)" (unknown panel), a class 3 device. 14,671 medical device reports carry this product code, 0.1% of the MAUDE database, from May 2004 to August 2026.
2,994 reports arrived in the 12 months to August 2026, up 92% from 1,559 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (54.1%), malfunction (43.9%) and death (1.9%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Valitude X4 Crt-P | 2,133 | 834 | 0.8% | 38.3% |
| Visionist X4 Crt-P | 1,776 | 877 | 0.2% | 51% |
| Percepta Quad CRT-P MRI SureScan | 1,539 | 261 | 2.3% | 48.7% |
| Quadra Allure MP CRT-P | 1,278 | 205 | 2.2% | 60.3% |
| Invive | 734 | 4 | 0.1% | 10.7% |
| Visionist Crt-P | 623 | 278 | 0.6% | 52.6% |
| Valitude Crt-P | 595 | 221 | 0.3% | 45.4% |
| Percepta CRT-P MRI SureScan | 549 | 97 | 1.3% | 42.6% |
| Accolade | 479 | 4 | 1.5% | 36.3% |
| Quadra Allure MP RF CRT-P | 392 | 17 | 6.1% | 58.2% |
| Contak Renewal Tr | 361 | 0 | 3.5% | 37.6% |
| Percepta Quad Crtp | 327 | 0 | 0% | 35% |
| Anthem Rf Crt-P | 300 | 0 | 7.3% | 57.3% |
| Solara Quad CRT-P MRI SureScan | 273 | 40 | 2.2% | 42.9% |
| Allure Quadra RF CRT-P | 267 | 6 | 5.9% | 60.9% |
| Intua | 250 | 5 | 0% | 11.1% |
| Serena Quad CRT-P MRI SureScan | 241 | 38 | 1.7% | 42.3% |
| Ingenio | 224 | 493 | 0.8% | 29.4% |
| Solara CRT-P MRI SureScan | 162 | 22 | 3.7% | 48.1% |
| Allure RF | 108 | 43 | 3% | 58.6% |
| Corox Otw-S 85-Bp | 74 | 4 | 1.4% | 39.6% |
| Corox Otw-S 75-Bp | 62 | 0 | 1.3% | 40.9% |
| Corox Otw 85-Bp | 60 | 0 | 0.5% | 43.5% |
| Anthem Rf | 46 | 0 | 4.3% | 77.4% |
| Corox OTW-L 85-BP | 37 | 5 | 1.1% | 43.1% |
| Corox Otw-L 75-Bp | 31 | 1 | 0.6% | 45.5% |
| Reply | 13 | 9 | 1.5% | 51.2% |
| Contak Renewal | 6 | 0 | 4.8% | 60.4% |
| Consulta Crt-P | 3 | 5 | 4.7% | 38.8% |
| Pacemaker | 3 | 15 | 5.9% | 18.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Medtronic Europe Sarl | 2,207 | 15% |
| St Jude Medical Crm-Sylmar | 1,662 | 11.3% |
| Boston Scientific | 1,593 | 10.9% |
| Guidant Crm Clonmel Ireland | 1,136 | 7.7% |
| Biotronik Se & Kg | 611 | 4.2% |
| St Jude Medical Crm-Sunnyvale | 234 | 1.6% |
| Cardiac Pacemakers | 122 | 0.8% |
| St Jude Medical Crmd | 120 | 0.8% |
| Abbott Medical Crm-Sylmar | 90 | 0.6% |
| St Jude Medical Crm-Kista | 71 | 0.5% |
| Ipg Mfg Switzerland | 46 | 0.3% |
| St Jude Medical Cardiac Rhythm Management Division | 42 | 0.3% |
| Biotronik And | 23 | 0.2% |
| Biotronik | 14 | 0.1% |
| Guidant Puerto Rico | 13 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Premature discharge of battery | 2,711 | 18.5% |
| Incorrect, inadequate or imprecise result or readings | 1,601 | 10.9% |
| Over-sensing | 1,532 | 10.4% |
| Pacing problem | 1,322 | 9% |
| High impedance | 914 | 6.2% |
| Failure to capture | 621 | 4.2% |
| Signal artifact/noise | 602 | 4.1% |
| Interrogation problem | 399 | 2.7% |
| Defective devicethe device was defective | 338 | 2.3% |
| Battery problema problem with the battery | 314 | 2.1% |
| Pacemaker found in back-up mode | 290 | 2% |
| Inappropriate or unexpected reset | 287 | 2% |
| Low impedance | 255 | 1.7% |
| Device operates differently than expectedthe device behaved unexpectedly | 252 | 1.7% |
| Unable to obtain readings | 243 | 1.7% |
| Data problem | 237 | 1.6% |
| Under-sensing | 229 | 1.6% |
| Mechanical problema mechanical problem | 224 | 1.5% |
| High capture threshold | 218 | 1.5% |
| Insufficient device problem information | 196 | 1.3% |
Questions about pulse generator, pacemaker, implantable, with cardiac resynchronization (crt-p) reports
What is product code NKE?
FDA's classification code for "Pulse generator, pacemaker, implantable, with cardiac resynchronization (crt-p)", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
14,671 reports through August 2026, 2,994 of them in the latest 12 months.
Which brands appear most often?
Valitude X4 Crt-P (2,133), Visionist X4 Crt-P (1,776), Percepta Quad CRT-P MRI SureScan (1,539), Quadra Allure MP CRT-P (1,278) and Invive (734). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.